| Issue Date | Title | Author(s) |
| 2-Nov-2023 | Alrizomadlin (APG-115) Alone or Combined with Azacitidine (AZA) in Patients (pts) with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Relapsed or Progressive Higher-Risk Myelodysplastic Syndrome (HR-MDS): Phase 1b Trial Results | Qi, Junyuan; Wei, Xudong; Li, Qiubai; Chang, Chukang; Zhou, Fuling; Huang, Jianying; Zhang, Yu; Xu, Chongyuan; Tang, Xiaowen; Jiang, Qian; Li, Junmin; Qin, Qun; He, Qun; Gao, Sujun; Liu, Liping; Chen, Zi; Yu, Min; Wang, Jing; Men, Lichuang; Wang, Hengbang; Ahmad, Mohammad; Yang, Dajun; Zhai, Yifan; Wang, Jianxiang |
| Dec-2020 | Cytotoxic secondary metabolites from the vulnerable conifer Cephalotaxus oliveri and its associated endophytic fungus Alternaria alternate Y-4-2 | Ma, Guang-Lei; Guo, Nan; Wang, Xi-Ling; Li, Junmin; Jin, Ze-Xin; Han, Yuqiao; Dong, Su-Zhen; Xiong, Juan; Hu, Jin-Feng |
| 21-Apr-2020 | Distinct modes of manipulation of rice auxin response factor OsARF17 by different plant RNA viruses for infection | Zhang, Hehong; Li, Lulu; He, Yuqing; Qin, Qingqing; Chen, Changhai; Wei, Zhongyan; Tan, Xiaoxiang; Xie, Kaili; Zhang, Ruifang; Hong, Gaojie; Li, Jing; Li, Junmin; Yan, Chengqi; Yan, Fei; Li, Yi; Chen, Jianping; Sun, Zongtao |
| 2014 | Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study | Yang, Renchi; Hou, Ming; Li, Junmin; Jin, Jie; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui; Du, Xin; Niu, Ting; Ke, Xiaoyan; Wang, Jianmin; Liu, Jing; Sun, Jing; Zhao, Yongqiang; Lu, Hua; Guo, Haiyi; Hsu, Belinda |
| 2018 | Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study | Yang, Renchi; Liu Xiaofan; Li, Junmin; Hou, Ming; Jie, Jin; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui |
| Nov-2020 | Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study | Liu, Xiaofan; Hou, Ming; Li, Junmin; Jin, Jie; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui; Yang, Renchi |
| 2-Nov-2023 | A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas | Song, Yuqin; Li, Zengjun; Wu, Huijing; Jin, Jie; Zhou, Hui; Zhou, Keshu; Zhang, Liling; Peng, Zhigang; Zhang, Zhiye; Cen, Hong; Jia, Youchao; Shuang, Yuerong; Li, Zhiming; Yang, Haiyan; Zou, Liqun; Li, Zhifeng; Zhang, Zhihui; Li, Junmin; Cao, Junning; Qiu, Lugui; Wu, Shaojie; Gong, Tiejun; Xu, Xiaohong; Wang, Zhen; Zhu, Jun |
| 2017 | Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia | Yang, Renchi; Li, Junmin; Jin, Jie; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui; Hou, Ming |
| 15-Apr-2023 | The Oral PI3Kd Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial | Wang, Tingyu; Sun, Xiuhua; Qiu, Lihua; Su, Hang; Cao, Junning; Li, Zhiming; Song, Yuqin; Zhang, Li; Li, Dengju; Wu, Huijing; Zhang, Wei; Li, Junmin; Zhou, Keshu; Zhou, Hui; Yang, Yu; Li, Zhifeng; Cen, Hong; Cai, Zhen; Zhang, Zhihui; Fu, Weijun; Jin, Jie; Li, Fei; Wu, Weixin; Gu, Xuekui; Zhu, Weiliang; Liu, Lihong; Li, Zengjun; Yi, Shuhua; Bao, Hanying; Xu, Zusheng; Qiu, Lugui |
| 2018 | Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from t | Fu, Weijun; Lu, Jin; Jin, Jie; Xu, Yan; Wu, Depei; Zhou, Dao-bin; Ke, Xiaoyan; Du, Xin; Chen, Xiequn; Chng, Wee Joo; Kim, Kihyun; Li, Junmin; Lee, Jae Hoon; Liu, Jing; Goh, Yeow Tee; Wu, Kwang-Wei; Wang, Hui; Liu, Guohui; Skacel, Tomas; Wan, Hui; Berg, Deborah |
| May-2020 | Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection | Liu, Kaiyan; Wu, Depei; Li, Junmin; Chen, Hu; Ning, Hongmei; Zhao, Ting; Dai, Haiping; Chen, Li; Mangin, Eric; Winchell, Gregory A.; Waskin, Hetty; Jiang, Jun; Qiu, Yanping; Zhao, Xu Min |
| 2017 | Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study | Hou, Jian; Jin, Jie; Xu, Yan; Wu, Depei; Ke, Xiaoyan; Zhou, Daobin; Lu, Jin; Du, Xin; Chen, Xiequn; Li, Junmin; Liu, Jing; Gupta, Neeraj; Hanley, Michael J.; Li, Hongmei; Hua, Zhaowei; Wang, Bingxia; Zhang, Xiaoquan; Wang, Hui; van de Velde, Helgi; Richardson, Paul G.; Moreau, Philippe |
| 2-Nov-2023 | Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide | Chen, Li; Zhu, Hongming; Dong, Fangyi; Li, Yan; Liu, Qifa; Hu, Yu; Zhang, Yicheng; Jin, Jie; Hu, Jianda; Liu, Ting; Wu, Depei; Chen, Jieping; Lai, Yongrong; Wang, Jianxiang; Li, Juan; Li, Jianyong; Du, Xin; Wang, Xin; Yang, Mingzhen; Yan, Jinsong; Ouyang, Guifang; Liu, Li; Hou, Ming; Huang, Xiaojun; Jin, Wen; Zhu, Yongmei; Li, Jian; Wang, Kankan; Chen, Zhu; Chen, Sai-Juan; Li, Junmin |
| Jul-2023 | Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in China | Zhou, Hu; Zhou, Jianfeng; Wu, Depei; Ma, Liping; Du, Xin; Niu, Ting; Yang, Renchi; Liu, Jing; Zhang, Feng; Shi, Qingzhi; Wang, Xiuli; Jing, Hongmei; Li, Junmin; Wang, Xin; Cui, Zhongguang; Zhou, Zeping; Hou, Ming; Shao, Zonghong; Jin, Jie; Li, Wenqian; Ren, Hanyun; Hu, Jianda; Shen, Jianliang; Liu, Li; Zeng, Yun; Zhou, Jin; Liu, Xin; Shen, Yunfeng; Ding, Kai; Taira, Tadaaki; Cai, Huacong; Zhao, Yongqiang |
| Jul-2023 | Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in China | Zhou, Hu; Zhou, Jianfeng; Wu, Depei; Ma, Liping; Du, Xin; Niu, Ting; Yang, Renchi; Liu, Jing; Zhang, Feng; Shi, Qingzhi; Wang, Xiuli; Jing, Hongmei; Li, Junmin; Wang, Xin; Cui, Zhongguang; Zhou, Zeping; Hou, Ming; Shao, Zonghong; Jin, Jie; Li, Wenqian; Ren, Hanyun; Hu, Jianda; Shen, Jianliang; Liu, Li; Zeng, Yun; Zhou, Jin; Liu, Xin; Shen, Yunfeng; Ding, Kai; Taira, Tadaaki; Cai, Huacong; Zhao, Yongqiang |
| 2015 | Tamibarotene Compared to All-Trans Retinoic Acid (ATRA) As Add-on to Arsenic Trioxide (ATO) in Subjects with Relapsed Acute Promyelocytic Leukemia (APL) | Wang, Jianxiang; Mi, Yingchang; Jiang, Bin; Chen, Xiequn; Ji, Chunyan; Li, Yan; Zhao, Xielan; Lai, Yongrong; Hu, Yu; Tang, Aiping; Liu, Ting; Jin, Jie; Li, Junmin; Yang, Linhua; Li, Jinyong; Meng, Fanyi |
| 2015 | Tamibarotene Compared to All-Trans Retinoic Acid (ATRA) As Add-on to Arsenic Trioxide (ATO) in Subjects with Relapsed Acute Promyelocytic Leukemia (APL) | Wang, Jianxiang; Mi, Yingchang; Jiang, Bin; Chen, Xiequn; Ji, Chunyan; Li, Yan; Zhao, Xielan; Lai, Yongrong; Hu, Yu; Tang, Aiping; Liu, Ting; Jin, Jie; Li, Junmin; Yang, Linhua; Li, Jinyong; Meng, Fanyi |
